More compact doses for perioral treatment than for higher facial purposes are applied because the oral musculature responds additional strongly to the identical BTX-A dosing. Only one preparing of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indication and FDA acceptance lies in treatments of cervical dystonia. Even though